What is it about?
This review of 50 years of immunotherapy for substance use disorders focuses on vaccine clinical trials for nicotine, stimulants and opioids particularly on anti-fentanyl vaccines for the current lethal fentanyl epidemic.
Featured Image
Read the Original
This page is a summary of: Vaccines as Immunotherapies for Substance Use Disorders, American Journal of Psychiatry, May 2024, American Psychiatric Association,
DOI: 10.1176/appi.ajp.20230828.
You can read the full text:
Contributors
Be the first to contribute to this page
